Abionyx Pharma SA (ABNX) — Strategic Asset Allocation Index
Abionyx Pharma SA (ABNX) has a Strategic Asset Allocation Index of 35.6% as of June 2025. Strategic assets (PP&E of €1.93 Million plus long-term investments of €-) total €1.93 Million, measured against net assets of €5.41 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Abionyx Pharma SA to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Abionyx Pharma SA Strategic Asset Allocation Index (2015–2024)
This chart shows how Abionyx Pharma SA's Strategic Asset Allocation Index has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the index stands at 35.6%, representing strategic assets of €1.93 Million against net assets of €5.41 Million EUR. See ABNX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Abionyx Pharma SA (2015–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Abionyx Pharma SA from 2015 to 2024, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Abionyx Pharma SA market cap and net worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 26.7% | €1.98 Million | €1.98 Million | €- | €7.42 Million | ▼ -1.2 pp |
| 2023 | 28.0% | €2.21 Million | €2.21 Million | €- | €7.92 Million | ▼ -7.7 pp |
| 2022 | 35.7% | €2.56 Million | €2.56 Million | €- | €7.17 Million | ▲ +7.0 pp |
| 2021 | 28.7% | €3.07 Million | €3.07 Million | €- | €10.68 Million | ▲ +27.0 pp |
| 2020 | 1.7% | €115.00K | €115.00K | €- | €6.63 Million | ▲ +0.3 pp |
| 2019 | 1.4% | €93.00K | €93.00K | €- | €6.67 Million | ▲ +0.8 pp |
| 2018 | 0.6% | €23.00K | €23.00K | €- | €3.84 Million | ▼ -0.3 pp |
| 2017 | 0.9% | €82.00K | €82.00K | €- | €8.89 Million | ▲ +0.1 pp |
| 2016 | 0.8% | €122.00K | €122.00K | €- | €14.61 Million | ▲ +0.3 pp |
| 2015 | 0.5% | €169.00K | €169.00K | €- | €33.20 Million | — |